| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/ANNONC/MDL374 |
| P698 | PubMed publication ID | 17060487 |
| P50 | author | Gedske Daugaard | Q38329899 |
| Ulrik Lassen | Q39700481 | ||
| Jann Mortensen | Q50549404 | ||
| P2093 | author name string | B M Fischer | |
| H H Hansen | |||
| A Loft | |||
| A K Berthelsen | |||
| S W Langer | |||
| B I Petersen | |||
| P433 | issue | 2 | |
| P921 | main subject | lung cancer | Q47912 |
| bone scintigraphy | Q1928938 | ||
| P304 | page(s) | 338-345 | |
| P577 | publication date | 2006-10-23 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. | |
| P478 | volume | 18 |
| Q42786728 | 18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours |
| Q33391093 | A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report |
| Q35568776 | Appropriateness criteria of FDG PET/CT in oncology |
| Q40153342 | Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancer |
| Q28279774 | Bronchopulmonary neuroendocrine tumors |
| Q36839240 | Cardiothoracic manifestations of neuroendocrine tumours |
| Q34540472 | Detection of rib metastases in patients with lung cancer: a comparative study of MRI, CT and bone scintigraphy |
| Q36014679 | Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study |
| Q39486097 | Extrapulmonary Small Cell Carcinoma of the Seminal Vesicles and Prostate Demonstrated on 18F-FDG Positron Emission Tomography/Computed Tomography |
| Q35550676 | Functional imaging in lung cancer |
| Q43239945 | High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer |
| Q89967676 | Impact of 18F-FDG PET/CT in Staging Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| Q46102024 | Increasing Role of FDG-PET/CT in Detecting Bone Marrow Metastasis of Solid Tumors in Adults: An Analysis of Ten Patients. |
| Q33799242 | Is there any significance of lung cancer histology to compare the diagnostic accuracies of (18)F-FDG-PET/CT and (99m)Tc-MDP BS for the detection of bone metastases in advanced NSCLC? |
| Q36833865 | Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO) |
| Q36989079 | Management of small-cell lung cancer with radiotherapy-a pan-Canadian survey of radiation oncologists |
| Q30916925 | Metastatic extrapulmonary small cell carcinoma to the cerebellopontine angle: a case report and review of the literature |
| Q37927164 | Novel molecular imaging in lung and pleural diseases |
| Q84153487 | Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial |
| Q81737147 | Osteoblastic response as a healing reaction to chemotherapy mimicking progressive disease in patients with small cell lung cancer |
| Q37732292 | PET and PET-CT in radiation treatment planning for lung cancer |
| Q34993781 | Positron emission tomography/computed tomography for bone tumors (Review). |
| Q33657999 | Positron emission tomography/computerized tomography in lung cancer |
| Q38819166 | Present and future roles of FDG-PET/CT imaging in the management of lung cancer. |
| Q37413672 | Prognostic value of metabolic tumor burden in lung cancer |
| Q34419020 | Prognostic value of volumetric metabolic parameters measured by [18F]fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer |
| Q37626969 | Progress in the management of limited-stage small cell lung cancer |
| Q53014495 | Quantification of metabolic tumor activity and burden in patients with non-small-cell lung cancer: Is manual adjustment of semiautomatic gradient-based measurements necessary? |
| Q59587552 | Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer |
| Q38925887 | Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer |
| Q37358684 | Small cell carcinoma of the liver and biliary tract without jaundice |
| Q60021974 | Small cell lung cancer |
| Q26852956 | Staging and imaging of small cell lung cancer |
| Q36072024 | Surgical intervention for small-cell lung cancer: what is the surgical role? |
| Q48277835 | The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer. |
| Q53149549 | The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study. |
| Q33830236 | Triage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer |
| Q38016163 | Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers |
| Q41677756 | Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer |
| Q42864238 | What is the role of FDG-PET in thoracic oncology in 2010? |
| Q83308902 | Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer |
Search more.